Dennis Anderson, M.S.
Associate Vice President for Business Development and Industrial Relations
Dennis Anderson, an NDSU alumnus, joined the university in the Office of Technology Transfer. Mr. Anderson then served as Director of Business Development and Industrial Relations in the Office of the Vice President for Research, Creative Activities, and Technology Transfer after which he was named Assistant Vice President and then Associate Vice President.
He previously served as director of business development at Molecular Genetics, Inc. As director of business development and preclinical research and development for MGI PHARMA, Inc., Mr. Anderson was responsible for creation and management of all preclinical pharmacology and safety studies and trials with both private sector contract research organizations as well as leading academic health sciences centers in U.S., Europe, and Japan.
He has served as vice president of regulatory affairs and technology development for Algenix, Inc., and Biovirx, Inc., both Minnesota biotech startup companies. Anderson also co-founded Biotronix, Inc., a biopharamaceutical research and development company, and OutaBox Thinking, Inc., a biopharmaceutical consulting company. Mr. Anderson's expertise includes private sector research and development of biotechnology and bio-pharmaceutical products and specialty chemicals. He had personal responsibility for creation and management of multiple INDs (Investigational New Drug applications), IDEs (investigational Device Exemption applications), and NDAs (New Drug Applications) during his tenure with the private sector.
Mr. Anderson has over 25 years of experience in intellectual property management and protection, technology transfer and licensing, creation and management of entrepreneurial start-ups, and commercialization of high technologies, e.g., biotechnology, biopharmaceuticals. Mr. Anderson is especially knowledgeable in those regulatory activities related to research, development and commercialization of technologies and products that are regulated either by U.S. FDA, U.S. EPA, and USDA and EU-EMEA (European Union—European Medicines Agency), particularly as applied to preclinical and clinical research, and sponsored research in corporate and academic settings.